![Steven Chartier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Chartier
Amministratore Delegato presso
BioVentrix, Inc.
Patrimonio netto: 1 $ in data 31/01/2026
Profilo
Steven J.
Chartier is Co-President, Co-CEO, and Director at BioVentrix, Inc. since 2025.
Mr. Chartier is a Member of the Regulatory Affairs Professionals Society.
Former roles include Chief Operating Officer at BioVentrix, Inc. from 2021 to 2023; Vice President-Regulatory & Clinical Affairs at Anika Therapeutics, Inc. from 2017 to 2018; Chief Operating Officer at PixarBio Corp.
from 2016 to 2017; Director-Regulatory Affairs at NUCRYST Pharmaceuticals Corp.
from 2009 to 2013; Vice President-Operations & Regulatory Affairs at Infraredx, Inc. in 2013; Manager-Clinical Projects at Biogen, Inc.; VP-Regulatory Affairs & Regulatory Affairs at Augmenix, Inc.; Principal at Dana-Farber Cancer Institute, Inc.; and Coordinator-Clinical Trials at Beth Israel Deaconess Medical Center, Inc. Education includes undergraduate studies at St. Anselm College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
BioVentrix, Inc.
 BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures 1,93% | 12/02/2026 | 110.530 ( 1,93% ) | 1 $ | 31/01/2026 |
Posizioni attive di Steven Chartier
| Società | Posizione | Inizio |
|---|---|---|
Regulatory Affairs Professionals Society
 Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Corporate Officer/Principal | - |
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures | Amministratore Delegato | 15/01/2025 |
Precedenti posizioni note di Steven Chartier
| Società | Posizione | Fine |
|---|---|---|
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures | Direttore operativo | 01/12/2023 |
| ANIKA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2018 |
| PIXARBIO CORPORATION | Direttore operativo | 02/02/2017 |
Augmenix, Inc.
 Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | Consigliere Generale | - |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Corporate Officer/Principal | - |
Formazione di Steven Chartier
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
70
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures | Health Technology |
Infraredx, Inc.
 Infraredx, Inc. Medical SpecialtiesHealth Technology Develops cardiovascular imaging devices | Health Technology |
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes medical products that fight infection and inflammation | Health Technology |
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Commercial Services |
Augmenix, Inc.
Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | Health Technology |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
St. Anselm College
 St. Anselm College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
PixarBio Corp.
 PixarBio Corp. Other Consumer ServicesConsumer Services Develops pre-clinical and commercial novel neurological drug delivery systems | Consumer Services |
